Cargando…

Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control

OBJECTIVES: Quality assurance (QA) plays an integral role in Point of Care Testing (POCT) programs. Quality control (QC) is an important QA program component to ensure high quality results and enhanced patient care. The measurement of transcutaneous bilirubin (TcB) in the POCT setting is an essentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Heather Anne, Adams, Brenda Joanne, Venner, Allison Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868991/
https://www.ncbi.nlm.nih.gov/pubmed/33598521
http://dx.doi.org/10.1016/j.plabm.2021.e00206
_version_ 1783648551259078656
author Paul, Heather Anne
Adams, Brenda Joanne
Venner, Allison Anne
author_facet Paul, Heather Anne
Adams, Brenda Joanne
Venner, Allison Anne
author_sort Paul, Heather Anne
collection PubMed
description OBJECTIVES: Quality assurance (QA) plays an integral role in Point of Care Testing (POCT) programs. Quality control (QC) is an important QA program component to ensure high quality results and enhanced patient care. The measurement of transcutaneous bilirubin (TcB) in the POCT setting is an essential part of newborn care in Alberta, Canada. However, there is currently no available commercial QC material for TcB meters. An in-house developed QC material has been in use within a single TcB POCT program within Alberta. The objective of this study was to determine the performance of this QC material by other POCT staff and clinical end-users to assess whether its use could be expanded. DESIGN AND METHODS: Two levels of QC material were measured by POCT staff and clinical end-users across 12 different sites using the Dräger Jaundice Meter JM-103® and JM-105® meters. RESULTS: The performance of the QC material was acceptable when tested by POCT staff, was stable and reliable over time, and had an acceptable CV (≤8%). However, the data does not support use of the QC material by clinical end-users. CONCLUSIONS: The use of the QC material could be expanded into other TcB settings for use by POCT staff. Additional training and experience with the QC material by end-users is needed to facilitate QC use in the clinical setting.
format Online
Article
Text
id pubmed-7868991
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78689912021-02-16 Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control Paul, Heather Anne Adams, Brenda Joanne Venner, Allison Anne Pract Lab Med Article OBJECTIVES: Quality assurance (QA) plays an integral role in Point of Care Testing (POCT) programs. Quality control (QC) is an important QA program component to ensure high quality results and enhanced patient care. The measurement of transcutaneous bilirubin (TcB) in the POCT setting is an essential part of newborn care in Alberta, Canada. However, there is currently no available commercial QC material for TcB meters. An in-house developed QC material has been in use within a single TcB POCT program within Alberta. The objective of this study was to determine the performance of this QC material by other POCT staff and clinical end-users to assess whether its use could be expanded. DESIGN AND METHODS: Two levels of QC material were measured by POCT staff and clinical end-users across 12 different sites using the Dräger Jaundice Meter JM-103® and JM-105® meters. RESULTS: The performance of the QC material was acceptable when tested by POCT staff, was stable and reliable over time, and had an acceptable CV (≤8%). However, the data does not support use of the QC material by clinical end-users. CONCLUSIONS: The use of the QC material could be expanded into other TcB settings for use by POCT staff. Additional training and experience with the QC material by end-users is needed to facilitate QC use in the clinical setting. Elsevier 2021-01-28 /pmc/articles/PMC7868991/ /pubmed/33598521 http://dx.doi.org/10.1016/j.plabm.2021.e00206 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Paul, Heather Anne
Adams, Brenda Joanne
Venner, Allison Anne
Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control
title Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control
title_full Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control
title_fullStr Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control
title_full_unstemmed Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control
title_short Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control
title_sort improving quality of transcutaneous bilirubin measurements: value of in-house developed quality control
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868991/
https://www.ncbi.nlm.nih.gov/pubmed/33598521
http://dx.doi.org/10.1016/j.plabm.2021.e00206
work_keys_str_mv AT paulheatheranne improvingqualityoftranscutaneousbilirubinmeasurementsvalueofinhousedevelopedqualitycontrol
AT adamsbrendajoanne improvingqualityoftranscutaneousbilirubinmeasurementsvalueofinhousedevelopedqualitycontrol
AT vennerallisonanne improvingqualityoftranscutaneousbilirubinmeasurementsvalueofinhousedevelopedqualitycontrol